BUPIVACAINA 50mg 50mg / 10ml injectible solution medication leaflet

N01BB01 bupivacaine • Nervous system | Anesthetics, local | Amides

Bupivacainum is a local anesthetic commonly used for regional anesthesia and pain control during surgical procedures, childbirth, or other medical interventions. It works by blocking sodium channels in nerve cell membranes, thereby inhibiting the transmission of pain signals to the brain.

The medication is administered via epidural, spinal, or local injection, as directed by a doctor. The dosage and method of administration are adjusted based on the type of procedure and the patient's condition.

Common side effects include low blood pressure, nausea, dizziness, and headaches. In rare cases, more severe adverse effects such as systemic toxicity, which can affect the central nervous and cardiovascular systems, may occur.

Bupivacainum is not recommended for pregnant or breastfeeding women unless absolutely necessary and under strict medical supervision. Patients should inform their doctor about any other medications they are taking to avoid drug interactions. Additionally, administration should be performed by qualified medical personnel to minimize the risks associated with the use of this anesthetic.

General data about BUPIVACAINA 50mg 50mg / 10ml

Substance: bupivacaine

Date of last drug list: 01-07-2013

Commercial code: W14048001

Concentration: 50mg / 10ml

Pharmaceutical form: injectible solution

Quantity: 5

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for bupivacaine

2.5mg/ml, 25mg/10ml, 50mg/10ml, 5mg/ml